190:: To identify the early physiopathological events in Alzheimer’s disease and develop primary and secondary prevention programs, the BBRC launched the Alfa Study, together with the Pasqual Maragall Foundation and thanks to support of “la Caixa”. The Alfa Study is a research platform made by 2.700 participants without cognitive alterations, dedicated to the early detection and prevention of Alzheimer’s disease. The participants are between 45 and 71 years old, and majorly descendants of people with Alzheimer’s disease, so the cohort is enriched with genetic factors related to the disease.
196:: The BBRC has several international studies and collaborations, majorly dedicated to the early detection and prevention of Alzheimer’s disease. The Alfa Study +, the Barcelonaβeta Dementia Prevention Research Clinic, the Alfa Genetics, the European Prevention of Alzheimer’s Dementia (EPAD), the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) and TRIBEKA are some of the research projects that are carried out.
202:: The BBRC works with the pharmaceutical industry and with public-private projects in Alzheimer’s clinical research in order to test drugs that succeed to avoid or delay the onset of the disease. Clinical trials for the prevention of Alzheimer’s disease with companies such as Novartis, Araclon Blotech and Janssen are being or have been carried out in their facilities.
426:
263:
183:
prodromal phase, which occurs when the first symptoms of cognitive impairment appear, but the affected person continues being independent on a day-to-day basis. The program it’s structured in two research groups that collaborate closely from a clinical, cognitive, genetic and biomarker and neuroimaging perspective.
207:
personnel and equipment necessary to carry out clinical trials in human research. The BBRC‘s
Neuroimaging Platform offers the scientific community personalized integral service to execute research projects that take into account the acquisition, management and processing of cerebral images by magnetic resonance.
178:
The
Barcelonaβeta Brain Research Center (BBRC) is a research center dedicated to the prevention of the Alzheimer’s Disease and the study of the cognitive functions affected in healthy and pathological aging. The Pasqual Maragall Foundation, with the support of the Pompeu Fabra University, was created
182:
The center’s mail activity is carried out in the
Alzheimer’s Prevention Program, led by Dr. Jose Luís Molinuevo. The program focuses on the pre-clinical phase of the disease, characterized by a series of changes in the brain that can start up to 20 years before the onset of the symptoms, and on the
169:
The
Foundation’s objective is to promote scientific research in the field of Alzheimer’s disease, related neurodegenerative diseases and neuroscience in general. Another of its objectives is to provide technical support and advisory services, as well as transferring its knowledge in the areas that
206:
The BBRC shares its headquarters with the
Pasqual Maragall Foundation, at 30 Wellington Street in Barcelona, in the Ciutadella Campus of the Pompeu Fabra University. Inaugurated in 2016, its facilities include a state-of-the-art 3T magnetic resonance dedicated exclusively to research, and the
152:
Private and independent, the
Pasqual Maragall Foundation counts on the economic support of partner enterprises and a network of associates and donors that make the project viable. Regarding its governing bodies, Dr.
170:
are specific to it. Another line of action included in its foundational mission is spreading the results of its scientific activities and involving society in relation to the knowledge obtained.
479:
249:
142:
319:
484:
224:
145:, who had been diagnosed with this neurodegenerative disease in 2007. Its headquarters are located in the Ciutadella Campus of the
344:
146:
97:
320:"La Fundación Pasqual Maragall impulsa el primer estudio mundial para la detección del riesgo de demencia"
126:
86:
402:
287:
369:
489:
138:
377:
295:
243:
228:
134:
50:
32:
158:
473:
154:
427:"Pasqual Maragall Foundation - Barcelonabeta Brain Research Center — ERA-LEARN"
264:"Pasqual Maragall Foundation - Barcelonabeta Brain Research Center — ERA-LEARN"
381:
370:"La Fundación Maragall tiene ya 2.000 voluntarios para estudiar el alzheimer"
299:
130:
110:
60:
403:"Taking part in an Alzheimer's study at the Pasqual Maragall Foundation"
125:
is a private, non-profit foundation dedicated to scientific research of
462:
161:
is the president and
Pasqual Maragall, is the honorary president.
179:
it in 2012 and it’s currently directed by Dr. Arcadi
Navarro.
455:
103:
93:
82:
74:
66:
56:
46:
38:
28:
174:The Barcelonaβeta Brain Research Center (BBRC)
8:
456:Pasqual Maragall Foundation official website
16:
345:"The ALFA study (Alzheimer's and Families)"
15:
143:President of the Generalitat de Catalunya
368:Guerrero, David Fernández (2013-07-23).
133:as a result of the public commitment of
216:
248:: CS1 maint: archived copy as title (
241:
7:
480:Medical research institutes in Spain
157:is the director of the Foundation,
129:. It was founded in April 2008 in
14:
485:Biomedical research foundations
288:"Maragall contra el alzhéimer"
1:
22:
401:Alkin, Alara (2018-08-30).
123:Pasqual Maragall Foundation
17:Pasqual Maragall Foundation
506:
294:(in Spanish). 2008-06-20.
23:Fundació Pasqual Maragall
21:
147:Pompeu Fabra University
98:Pompeu Fabra University
127:Alzheimer's disease
87:Alzheimer's disease
18:
139:Mayor of Barcelona
194:Research Projects
119:
118:
497:
459:
458:
441:
440:
438:
437:
431:www.era-learn.eu
423:
417:
416:
414:
413:
398:
392:
391:
389:
388:
365:
359:
358:
356:
355:
341:
335:
334:
332:
331:
316:
310:
309:
307:
306:
284:
278:
277:
275:
274:
268:www.era-learn.eu
260:
254:
253:
247:
239:
237:
236:
227:. Archived from
221:
135:Pasqual Maragall
51:Pasqual Maragall
33:Pasqual Maragall
19:
505:
504:
500:
499:
498:
496:
495:
494:
470:
469:
454:
453:
450:
445:
444:
435:
433:
425:
424:
420:
411:
409:
400:
399:
395:
386:
384:
367:
366:
362:
353:
351:
343:
342:
338:
329:
327:
318:
317:
313:
304:
302:
286:
285:
281:
272:
270:
262:
261:
257:
240:
234:
232:
225:"Archived copy"
223:
222:
218:
213:
200:Clinical trials
176:
167:
159:Diana Garrigosa
115:
24:
12:
11:
5:
503:
501:
493:
492:
487:
482:
472:
471:
466:
465:
463:Barcelona Beta
460:
449:
448:External links
446:
443:
442:
418:
393:
376:(in Spanish).
360:
336:
311:
279:
255:
215:
214:
212:
209:
204:
203:
197:
191:
175:
172:
166:
163:
149:in Barcelona.
117:
116:
114:
113:
107:
105:
101:
100:
95:
91:
90:
84:
80:
79:
76:
72:
71:
68:
64:
63:
58:
54:
53:
48:
44:
43:
40:
36:
35:
30:
26:
25:
13:
10:
9:
6:
4:
3:
2:
502:
491:
488:
486:
483:
481:
478:
477:
475:
468:
464:
461:
457:
452:
451:
447:
432:
428:
422:
419:
408:
404:
397:
394:
383:
379:
375:
371:
364:
361:
350:
346:
340:
337:
325:
324:La Vanguardia
321:
315:
312:
301:
297:
293:
289:
283:
280:
269:
265:
259:
256:
251:
245:
231:on 2007-07-06
230:
226:
220:
217:
210:
208:
201:
198:
195:
192:
189:
186:
185:
184:
180:
173:
171:
164:
162:
160:
156:
150:
148:
144:
140:
136:
132:
128:
124:
112:
109:
108:
106:
102:
99:
96:
92:
88:
85:
81:
77:
73:
69:
65:
62:
59:
55:
52:
49:
45:
41:
37:
34:
31:
27:
20:
467:
434:. Retrieved
430:
421:
410:. Retrieved
406:
396:
385:. Retrieved
373:
363:
352:. Retrieved
349:Senesciencia
348:
339:
328:. Retrieved
326:. 2018-05-16
323:
314:
303:. Retrieved
291:
282:
271:. Retrieved
267:
258:
233:. Retrieved
229:the original
219:
205:
199:
193:
187:
181:
177:
168:
151:
122:
120:
94:Headquarters
75:Legal status
141:and former
29:Named after
474:Categories
436:2019-09-05
412:2019-09-05
387:2019-09-11
354:2019-09-05
330:2019-09-11
305:2019-09-11
273:2019-09-05
235:2009-04-16
211:References
188:Alfa Study
165:Objectives
155:Jordi Camí
70:foundation
57:Founded at
42:April 2008
490:Catalonia
382:1134-6582
300:1134-6582
137:, former
131:Barcelona
111:Barcelona
61:Barcelona
39:Formation
244:cite web
104:Location
89:research
374:El País
292:El País
83:Purpose
47:Founder
407:QMENTA
380:
298:
78:active
378:ISSN
296:ISSN
250:link
121:The
67:Type
476::
429:.
405:.
372:.
347:.
322:.
290:.
266:.
246:}}
242:{{
439:.
415:.
390:.
357:.
333:.
308:.
276:.
252:)
238:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.